Langan, Robert A.
Boyken, Scott E.
Ng, Andrew H.
Samson, Jennifer A.
Dods, Galen
Westbrook, Alexandra M.
Nguyen, Taylor H.
Lajoie, Marc J.
Chen, Zibo
Berger, Stephanie
Mulligan, Vikram Khipple
Dueber, John E.
Novak, Walter R. P.
El-Samad, Hana
Baker, David
Article History
Received: 12 October 2018
Accepted: 19 June 2019
First Online: 24 July 2019
Competing interests
: : R.A.L., S.E.B., D.B., W.R.P.N. and M.J.L. have filed a provisional patent describing the design, composition and function of LOCKR switches, keys and scaffolds. R.A.L., A.H.N., S.E.B., M.J.L., D.B. and H.E.-S. have filed a provisional patent application describing the design, composition and function of degronLOCKR constructs. D.B., R.A.L., S.E.B. and M.J.L. hold equity in Lyell Immunopharma. D.B. holds equity in Sana Biotechnology.